Company or ticker...

BioTech

uniQURE

uniQure is a pioneering gene therapy company dedicated to delivering potentially curative, one-time treatments for rare and severe genetic diseases using its proprietary adeno-associated virus (AAV) technology platform.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

QURE

3.4B

181.2

n/a

103.45%

Key Facts

M. Cap

PS

PE

YTD

3.4B

181.2

n/a

103.45%

10MA

20MA

50MA

200MA

$QURE